New therapy, new challenges: The effects of long-term continuous flow left ventricular assist device on inflammation

International Journal of Cardiology

Volumn 215, Issue , 2016, Pages 424-430

  Grosman Rimon, Liza ^a   Billia, Filio ^a   Fuks, Avi ^a   Jacobs, Ira ^b   McDonald, Michael A ^a   Cherney, David Z ^c   Rao, Vivek ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Continuous flow left ventricular assist devices (CF LVADs); Heart failure (HF) inflammatory biomarkers

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

CEREBROVASCULAR ACCIDENT; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; DETERIORATION; DISEASE ASSOCIATION; HEART RIGHT VENTRICLE FAILURE; HUMAN; INFLAMMATION; LIVER FAILURE; LONG TERM CARE; MULTIPLE ORGAN FAILURE; NONHUMAN; PHYSICAL ACTIVITY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE; ADVERSE EFFECTS; CHEMICALLY INDUCED; COMPLICATION; HEART ASSIST DEVICE; HEART FAILURE; PATHOPHYSIOLOGY; RENAL INSUFFICIENCY; STROKE;

HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; INFLAMMATION; MULTIPLE ORGAN FAILURE; RENAL INSUFFICIENCY; STROKE;

EID: 84964844674     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.04.133     Document Type: Review

References (107)

1. G.M. Wieselthaler, H. Schima, M. Hiesmayr, R. Pacher, G. Laufer, G.P. Noon, M. DeBakey, and E. Wolner First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation Circulation 101 2000 356 359
2. D.J. Farrar, and J.D. Hill Univentricular and biventricular Thoratec VAD support as a bridge to transplantation Ann. Thorac. Surg. 55 1993 276 282
3. E.A. Rose, A.C. Gelijns, A.J. Moskowitz, D.F. Heitjan, L.W. Stevenson, W. Dembitsky, J.W. Long, D.D. Ascheim, A.R. Tierney, R.G. Levitan, J.T. Watson, P. Meier, N.S. Ronan, P.A. Shapiro, R.M. Lazar, L.W. Miller, L. Gupta, O.H. Frazier, P. Desvigne-Nickens, M.C. Oz, V.L. Poirier, and Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group Long-term mechanical left ventricular assistance for end-stage heart failure N. Engl. J. Med. 345 2001 1435 1443
4. D.J. Farrar, W.R. Holman, L.R. McBride, R.L. Kormos, T.B. Icenogle, P.J. Hendry, C.H. Moore, D.Y. Loisance, A. El-Banayosy, and H. Frazier Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function J. Heart Lung Transplant. 21 2002 516 521
5. R. John, A. Boyle, F. Pagani, and L. Miller Physiologic and pathologic changes in patients with continuous-flow ventricular assist devices J. Cardiovasc. Transl. Res. 2 2009 154 158
6. M.S. Slaughter, J.G. Rogers, C.A. Milano, S.D. Russell, J.V. Conte, D. Feldman, B. Sun, A.J. Tatooles, R.M. Delgado 3rd, J.W. Long, T.C. Wozniak, W. Ghumman, D.J. Farrar, O.H. Frazier, and HeartMate II Investigators Advanced heart failure treated with continuous-flow left ventricular assist device N. Engl. J. Med. 361 2009 2241 2251
7. J.K. Kirklin, D.C. Naftel, R.L. Kormos, L.W. Stevenson, F.D. Pagani, M.A. Miller, K.L. Ulisney, J.T. Baldwin, and J.B. Young Third INTERMACS Annual Report: the evolution of destination therapy in the United States J. Heart Lung Transplant. 30 2011 115 123
8. G.M. Wieselthaler, H. Schima, M. Dworschak, M. Quittan, M. Nuhr, M. Czerny, G. Seebacher, L. Huber, M. Grimm, and E. Wolner First experiences with outpatient care of patients with implanted axial flow pumps Artif. Organs 25 2001 331 335
9. J.K. Kirklin, D.C. Naftel, R.L. Kormos, L.W. Stevenson, F.D. Pagani, M.A. Miller, K.L. Ulisney, J.T. Baldwin, and J.B. Young Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants J. Heart Lung Transplant. 29 2010 1 10
10. F.D. Pagani, L.W. Miller, S.D. Russell, K.D. Aaronson, R. John, A.J. Boyle, J.V. Conte, R.C. Bogaev, T.E. MacGillivray, Y. Naka, D. Mancini, H.T. Massey, L. Chen, C.T. Klodell, J.M. Aranda, N. Moazami, G.A. Ewald, D.J. Farrar, O.H. Frazier, and HeartMate II Investigators Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device J. Am. Coll. Cardiol. 54 2009 312 321
11. L.W. Miller, F.D. Pagani, S.D. Russell, R. John, A.J. Boyle, K.D. Aaronson, J.V. Conte, Y. Naka, D. Mancini, R.M. Delgado, T.E. MacGillivray, D.J. Farrar, O.H. Frazier, and HeartMate II Clinical Investigators Use of a continuous-flow device in patients awaiting heart transplantation N. Engl. J. Med. 357 2007 885 896
12. F. Feihl, L. Liaudet, and B. Waeber The macrocirculation and microcirculation of hypertension Curr. Hypertens. Rep. 11 2009 182 189
13. R. Schindler Causes and therapy of microinflammation in renal failure Nephrol. Dial. Transplant. 19 Suppl. 5 2004 V34 V40
14. B.W. McColl, S.M. Allan, and N.J. Rothwell Systemic inflammation and stroke: aetiology, pathology and targets for therapy Biochem. Soc. Trans. 35 2007 1163 1165
15. A. Yndestad, J.K. Damas, E. Oie, T. Ueland, L. Gullestad, and P. Aukrust Systemic inflammation in heart failure - the whys and wherefores Heart Fail. Rev. 11 2006 83 92
16. M. Rothenburger, M. Wilhelm, D. Hammel, C. Schmid, G. Plenz, T.D. Tjan, H. Baba, B. Schluter, H.H. Scheld, M.C. Deng, and M. Erren Immune response in the early postoperative period after implantation of a left-ventricular assist device system Transplant. Proc. 33 2001 1955 1957
17. D.C. Corry, A.,. DeLucia 3rd, H. Zhu, R.R. Radcliffe, G.R. Brevetti, H. El-Khatib, S.J. Vance, B.R. Moyer, W.G. Cotts, and W.E. Richenbacher Time course of cytokine release and complement activation after implantation of the HeartMate left ventricular assist device ASAIO J. 44 1998 M347 M351
18. M.C. Deng, M. Erren, T.D. Tjan, N. Tamminga, B. Werntze, P. Zimmermann, M. Weyand, D. Hammel, C. Schmidt, and H.H. Scheld Left ventricular assist system support is associated with persistent inflammation and temporary immunosuppression Thorac. Cardiovasc. Surg. 47 Suppl. 2 1999 326 331
19. A.H. Bruggink, M.F. van Oosterhout, N. De Jonge, F.H. Gmelig-Meyling, and R.A. De Weger TNFalpha in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device Transpl. Immunol. 19 2008 64 68
20. D.J. Goldstein, N. Moazami, J.A. Seldomridge, H. Laio, R.C. Ashton Jr., Y. Naka, D.J. Pinsky, and M.C. Oz Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels Ann. Thorac. Surg. 63 1997 971 974
21. M. Loebe, A. Koster, S. Sanger, E.V. Potapov, H. Kuppe, G.P. Noon, and R. Hetzer Inflammatory response after implantation of a left ventricular assist device: comparison between the axial flow MicroMed DeBakey VAD and the pulsatile Novacor device ASAIO J. 47 2001 272 274
22. N.H. Thoennissen, A. Allroggen, M. Ritter, R. Dittrich, C. Schmid, H.H. Schmid, E.B. Ringelstein, and D.G. Nabavi Influence of inflammation and pump dynamic on cerebral microembolization in patients with Continuous-Flow DeBakey LVAD ASAIO J. 52 2006 243 247
23. L. Grosman-Rimon, M.A. McDonald, I. Jacobs, L.C. Tumiati, S.P. Bar-Ziv, D.J. Shogilev, A.G. Mociornita, A. Ghashghai, A. Chruscinski, D.Z. Cherney, and V. Rao Markers of inflammation in recipients of continuous flow left ventricular assist devices ASAIO J. 31 2014 348 356
24. L. Grosman-Rimon, I. Jacobs, L.C. Tumiati, M.A. McDonald, S.P. Bar-Ziv, A. Fuks, H. Kawajiri, J. Lazarte, A. Ghashghai, D.J. Shogilev, D.Z. Cherney, and V. Rao Longitudinal assessment of inflammation in recipients of continuous-flow left ventricular assist devices Can. J. Cardiol. 31 2015 348 356
25. G. Torre-Amione, S.J. Stetson, K.A. Youker, J.B. Durand, B. Radovancevic, R.M. Delgado, O.H. Frazier, M.L. Entman, and G.P. Noon Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support: a potential mechanism for cardiac recovery Circulation 100 1999 1189 1193
26. S. Maybaum, S. Epstein, A. Beniaminovitz, M. Di Tullio, M. Oz, S.R. Bergmann, and D. Mancini Partial loading of the left ventricle during mechanical assist device support is associated with improved myocardial function, blood flow and metabolism and increased exercise capacity J. Heart Lung Transplant. 21 2002 446 454
27. F. Grabellus, B. Levkau, A. Sokoll, H. Welp, C. Schmid, M.C. Deng, A. Takeda, G. Breithardt, and H.A. Baba Reversible activation of nuclear factor-kappaB in human end-stage heart failure after left ventricular mechanical support Cardiovasc. Res. 53 2002 124 130
28. M.S. Bedi, R.J. Alvarez Jr., T. Kubota, R. Sheppard, R.L. Kormos, M.P. Siegenthaler, A.M. Feldman, C.F. McTiernan, and D.M. McNamara Myocardial Fas and cytokine expression in end-stage heart failure: impact of LVAD support Clin. Transl. Sci. 1 2008 245 248
29. V. Thohan, S.J. Stetson, S.F. Nagueh, C. Rivas-Gotz, M.M. Koerner, J.A. Lafuente, M. Loebe, G.P. Noon, and G. Torre-Amione Cellular and hemodynamics responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-Noon left ventricular assist device: a comparative analysis with pulsatile-type devices J. Heart Lung Transplant. 24 2005 566 575
30. R. Caruso, C. Caselli, L. Cozzi, J. Campolo, F. Viglione, M. Parolini, S. Nonini, S. Trunfio, A. D'Amico, G. Pelosi, D. Giannessi, P. Marraccini, M. Frigerio, and O. Parodi Myocardial interleukin-6 in the setting of left ventricular mechanical assistance: relation with outcome and C-reactive protein Clin. Chem. Lab. Med. 53 2014 1359 1366
31. N.C. Dang, V.K. Topkara, M. Mercando, J. Kay, K.H. Kruger, M.S. Aboodi, M.C. Oz, and Y. Naka Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure J. Heart Lung Transplant. 25 2006 1 6
32. M.N. Kavarana, M.S. Pessin-Minsley, J. Urtecho, K.A. Catanese, M. Flannery, M.C. Oz, and Y. Naka Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem Ann. Thorac. Surg. 73 2002 745 750
33. O.H. Frazier, E.A. Rose, M.C. Oz, W. Dembitsky, P. McCarthy, B. Radovancevic, V.L. Poirier, K.A. Dasse, and HeartMate LVAS Investigators. Left Ventricular Assist System Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation J. Thorac. Cardiovasc. Surg. 122 2001 1186 1195
34. R.L. Kormos, J.J. Teuteberg, F.D. Pagani, S.D. Russell, R. John, L.W. Miller, T. Massey, C.A. Milano, N. Moazami, K.S. Sundareswaran, D.J. Farrar, and HeartMate II Clinical Investigators Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes J. Thorac. Cardiovasc. Surg. 139 2010 1316 1324
35. N.D. Patel, E.S. Weiss, J. Schaffer, S.L. Ullrich, D.C. Rivard, A.S. Shah, S.D. Russell, and J.V. Conte Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices Ann. Thorac. Surg. 86 2008 832 840 (discussion 832-40)
36. G. Torre-Amione, R.E. Southard, M.M. Loebe, K.A. Youker, B. Bruckner, J.D. Estep, M. Tierney, and G.P. Noon Reversal of secondary pulmonary hypertension by axial and pulsatile mechanical circulatory support J. Heart Lung Transplant. 29 2010 195 200
37. F. Hennig, A.V. Stepanenko, H.B. Lehmkuhl, M. Kukucka, M. Dandel, T. Krabatsch, R. Hetzer, and E.V. Potapov Neurohumoral and inflammatory markers for prediction of right ventricular failure after implantation of a left ventricular assist device Gen. Thorac. Cardiovasc. Surg. 59 2011 19 24
38. D. Tousoulis, M. Charakida, and C. Stefanadis Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failure Int. J. Cardiol. 100 2005 347 353
39. S.D. Katz Mechanisms and implications of endothelial dysfunction in congestive heart failure Curr. Opin. Cardiol. 12 1997 259 264
40. S.D. Katz, K. Hryniewicz, I. Hriljac, K. Balidemaj, C. Dimayuga, A. Hudaihed, and A. Yasskiy Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure Circulation 111 2005 310 314
41. O. Amir, B. Radovancevic, R.M.,. Delgado 3rd, B. Kar, R. Radovancevic, M. Henderson, W.E. Cohn, and F.W. Smart Peripheral vascular reactivity in patients with pulsatile vs axial flow left ventricular assist device support J. Heart Lung Transplant. 25 2006 391 394
42. A.R. Travis, G.A. Giridharan, G.M. Pantalos, R.D. Dowling, S.D. Prabhu, M.S. Slaughter, M. Sobieski, A. Undar, D.J. Farrar, and S.C. Koenig Vascular pulsatility in patients with a pulsatile- or continuous-flow ventricular assist device J. Thorac. Cardiovasc. Surg. 133 2007 517 524
43. X. Lou, D.L. Templeton, R. John, and D.R. Dengel Effects of continuous flow left ventricular assist device support on microvascular endothelial function J. Cardiovasc. Transl. Res. 5 2012 345 350
44. R. John, S. Panch, J. Hrabe, P. Wei, A. Solovey, L. Joyce, and R. Hebbel Activation of endothelial and coagulation systems in left ventricular assist device recipients Ann. Thorac. Surg. 88 2009 1171 1179
45. R. Sansone, B. Stanske, S. Keymel, D. Schuler, P. Horn, D. Saeed, U. Boeken, R. Westenfeld, A. Lichtenberg, M. Kelm, and C. Heiss Macrovascular and microvascular function after implantation of left ventricular assist devices in end-stage heart failure: role of microparticles J. Heart Lung Transplant. 34 2015 921 932
46. P. Diehl, M. Aleker, T. Helbing, V. Sossong, F. Beyersdorf, M. Olschewski, C. Bode, and M. Moser Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation Interact. Cardiovasc. Thorac. Surg. 11 2010 133 137
47. J.A. Morgan, R.J. Brewer, H.W. Nemeh, B. Gerlach, D.E. Lanfear, C.T. Williams, and G. Paone Stroke while on long-term left ventricular assist device support: incidence, outcome, and predictors ASAIO J. 60 2014 284 289
48. R. John, F. Kamdar, K. Liao, M. Colvin-Adams, A. Boyle, and L. Joyce Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy Ann. Thorac. Surg. 86 2008 1227 1234 (discussion 1234-5)
49. H. Tsukui, A. Abla, J.J. Teuteberg, D.M. McNamara, M.A. Mathier, L.M. Cadaret, and R.L. Kormos Cerebrovascular accidents in patients with a ventricular assist device J. Thorac. Cardiovasc. Surg. 134 2007 114 123
50. A.J. Boyle, U.P. Jorde, B. Sun, S.J. Park, C.A. Milano, O.H. Frazier, K.S. Sundareswaran, D.J. Farrar, S.D. Russell, and HeartMate II Clinical Investigators Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients J. Am. Coll. Cardiol. 63 2014 880 888
51. T.S. Kato, T. Ota, P.C. Schulze, M. Farr, U. Jorde, H. Takayama, Y. Naka, T. Yamashita, and D.M. Mancini Asymmetric pattern of cerebrovascular lesions in patients after left ventricular assist device implantation Stroke 43 2012 872 874
52. T.J. Kleinig, and R. Vink Suppression of inflammation in ischemic and hemorrhagic stroke: therapeutic options Curr. Opin. Neurol. 22 2009 294 301
53. R. Jin, G. Yang, and G. Li Inflammatory mechanisms in ischemic stroke: role of inflammatory cells J. Leukoc. Biol. 87 2010 779 789
54. S.E. Lakhan, A. Kirchgessner, and M. Hofer Inflammatory mechanisms in ischemic stroke: therapeutic approaches J. Transl. Med. 7 2009 (97-5876-7-97)
55. G.V. Letsou, T.J. Myers, I.D. Gregoric, R. Delgado, N. Shah, K. Robertson, B. Radovancevic, and O.H. Frazier Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 months Ann. Thorac. Surg. 76 2003 1167 1170
56. B. Radovancevic, B. Vrtovec, E. de Kort, R. Radovancevic, I.D. Gregoric, and O.H. Frazier End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices J. Heart Lung Transplant. 26 2007 815 818
57. F. Kamdar, A. Boyle, K. Liao, M. Colvin-adams, L. Joyce, and R. John Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients J. Heart Lung Transplant. 28 2009 352 359
58. T. Masai, Y. Sawa, S. Ohtake, T. Nishida, M. Nishimura, N. Fukushima, T. Yamaguchi, and H. Matsuda Hepatic dysfunction after left ventricular mechanical assist in patients with end-stage heart failure: role of inflammatory response and hepatic microcirculation Ann. Thorac. Surg. 73 2002 549 555
59. R. Caruso, S. Trunfio, F. Milazzo, J. Campolo, R. De Maria, T. Colombo, M. Parolini, A. Cannata, C. Russo, R. Paino, M. Frigerio, L. Martinelli, and O. Parodi Early expression of pro- and anti-inflammatory cytokines in left ventricular assist device recipients with multiple organ failure syndrome ASAIO J. 56 2010 313 318
60. R. Caruso, A. Verde, M. Cabiati, F. Milazzo, C. Boroni, S. Del Ry, M. Parolini, C. Vittori, R. Paino, L. Martinelli, D. Giannessi, M. Frigerio, and O. Parodi Association of pre-operative interleukin-6 levels with Interagency Registry for Mechanically Assisted Circulatory Support profiles and intensive care unit stay in left ventricular assist device patients J. Heart Lung Transplant. 31 2012 625 633
61. R. Caruso, A. Verde, J. Campolo, F. Milazzo, C. Russo, C. Boroni, M. Parolini, S. Trunfio, R. Paino, L. Martinelli, M. Frigerio, and O. Parodi Severity of oxidative stress and inflammatory activation in end-stage heart failure patients are unaltered after 1 month of left ventricular mechanical assistance Cytokine 59 2012 138 144
62. K.T. Lappegard, G. Bergseth, J. Riesenfeld, A. Pharo, P. Magotti, J.D. Lambris, and T.E. Mollnes The artificial surface-induced whole blood inflammatory reaction revealed by increases in a series of chemokines and growth factors is largely complement dependent J. Biomed. Mater. Res. A 87 2008 129 135
63. C. Baufreton, L. Intrator, P.G. Jansen, H. te Velthuis, P. Le Besnerais, A. Vonk, J.P. Farcet, C.R. Wildevuur, and D.Y. Loisance Inflammatory response to cardiopulmonary bypass using roller or centrifugal pumps Ann. Thorac. Surg. 67 1999 972 977
64. D. Paparella, T.M. Yau, and E. Young Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update Eur. J. Cardiothorac. Surg. 21 2002 232 244
65. J. Rossaint, C. Berger, H. Van Aken, H.H. Scheld, P.K. Zahn, A. Rukosujew, and A. Zarbock Cardiopulmonary bypass during cardiac surgery modulates systemic inflammation by affecting different steps of the leukocyte recruitment cascade PLoS One 7 2012 e45738
66. H. Welp, A. Rukosujew, T.D. Tjan, A. Hoffmeier, V. Kosek, H.H. Scheld, and G. Drees Effect of pulsatile and non-pulsatile left ventricular assist devices on the renin-angiotensin system in patients with end-stage heart failure Thorac. Cardiovasc. Surg. 58 Suppl. 2 2010 S185 S188
67. R.,. Delgado 3rd, B. Radovancevic, E.K. Massin, O.H. Frazier, and C. Benedict Neurohormonal changes after implantation of a left ventricular assist system ASAIO J. 44 1998 299 302
68. K.B. James, P.M. McCarthy, J.D. Thomas, R. Vargo, R.E. Hobbs, S. Sapp, and E. Bravo Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure Circulation 92 1995 II191 II195
69. P. Noirhomme, L. Jacquet, M. Underwood, G. El Khoury, M. Goenen, and R. Dion The effect of chronic mechanical circulatory support on neuroendocrine activation in patients with end-stage heart failure Eur. J. Cardiothorac. Surg. 16 1999 63 67
70. S. Saito, S. Westaby, D. Piggot, S. Dudnikov, D. Robson, P.A. Catarino, C. Clelland, and C. Nojiri End-organ function during chronic nonpulsatile circulation Ann. Thorac. Surg. 74 2002 1080 1085
71. E. Tatsumi, K. Toda, Y. Taenaka, K. Miyazaki, T. Masuzawa, T. Nakatani, Y. Baba, A. Yagura, K. Eya, and Y. Wakisaka Acute phase responses of vasoactive hormones to non pulsatile systemic circulation ASAIO J. 41 1995 M460 M465
72. K. Fukae, R. Tominaga, S. Tokunaga, Y. Kawachi, T. Imaizumi, and H. Yasui The effects of pulsatile and nonpulsatile systemic perfusion on renal sympathetic nerve activity in anesthetized dogs J. Thorac. Cardiovasc. Surg. 111 1996 478 484
73. J.E. James, and M.B. Daly Comparison of the reflex vasomotor responses to separate and combined stimulation of the carotid sinus and aortic arch baroreceptors by pulsatile and non-pulsatile pressures in the dog J. Physiol. 209 1970 257 293
74. K. Toda, E. Tatsumi, Y. Taenaka, T. Masuzawa, and H. Takano Impact of systemic depulsation on tissue perfusion and sympathetic nerve activity Ann. Thorac. Surg. 62 1996 1737 1742
75. G. Grassi, C. Giannattasio, M. Failla, A. Pesenti, G. Peretti, E. Marinoni, N. Fraschini, S. Vailati, and G. Mancia Sympathetic modulation of radial artery compliance in congestive heart failure Hypertension 26 1995 348 354
76. S.G. Lage, L. Kopel, M.C. Monachini, C.J. Medeiros, F. Pileggi, J.F. Polak, and M.A. Creager Carotid arterial compliance in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy Am. J. Cardiol. 74 1994 691 695
77. S.G. Lage, L. Kopel, C.C. Medeiros, R.T. Carvalho, and M.A. Creager Angiotensin II contributes to arterial compliance in congestive heart failure Am. J. Physiol. Heart Circ. Physiol. 283 2002 H1424 H1429
78. D.A. Duprez, M.L. De Buyzere, E.R. Rietzschel, Y. Taes, D.L. Clement, D. Morgan, and J.N. Cohn Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients Eur. Heart J. 19 1998 1371 1376
79. M. Caprio, B.G. Newfell, A. la Sala, W. Baur, A. Fabbri, G. Rosano, M.E. Mendelsohn, and I.Z. Jaffe Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion Circ. Res. 102 2008 1359 1367
80. Y. Hashikabe, K. Suzuki, T. Jojima, K. Uchida, and Y. Hattori Aldosterone impairs vascular endothelial cell function J. Cardiovasc. Pharmacol. 47 2006 609 613
81. J.M. Luther, J.V. Gainer, L.J. Murphey, C. Yu, D.E. Vaughan, J.D. Morrow, and N.J. Brown Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism Hypertension 48 2006 1050 1057
82. Y. Ozawa, H. Kobori, Y. Suzaki, and L.G. Navar Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions Am. J. Physiol. Ren. Physiol. 292 2007 F330 F339
83. M. Ruiz-Ortega, M. Ruperez, O. Lorenzo, V. Esteban, J. Blanco, S. Mezzano, and J. Egido Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney Kidney Int. Suppl. 82 2002 S12 S22
84. D. Sorescu Smad3 mediates angiotensin II- and TGF-beta1-induced vascular fibrosis: Smad3 thickens the plot Circ. Res. 98 2006 988 989
85. S.D. Anker, and S. von Haehling Inflammatory mediators in chronic heart failure: an overview Heart 90 2004 464 470
86. D.L. Mann Inflammatory mediators and the failing heart: past, present, and the foreseeable future Circ. Res. 91 2002 988 998
87. C. Stumpf, C. Lehner, A. Yilmaz, W.G. Daniel, and C.D. Garlichs Decrease of serum levels of the anti-inflammatory cytokine interleukin-10 in patients with advanced chronic heart failure Clin. Sci. (Lond.) 105 2003 45 50
88. G. Torre-Amione, S. Kapadia, C. Benedict, H. Oral, J.B. Young, and D.L. Mann Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD) J. Am. Coll. Cardiol. 27 1996 1201 1206
89. P. Aukrust, T. Ueland, E. Lien, K. Bendtzen, F. Muller, A.K. Andreassen, I. Nordoy, H. Aass, T. Espevik, S. Simonsen, S.S. Froland, and L. Gullestad Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am. J. Cardiol. 83 1999 376 382
90. P. Aukrust, T. Ueland, F. Muller, A.K. Andreassen, I. Nordoy, H. Aas, J. Kjekshus, S. Simonsen, S.S. Froland, and L. Gullestad Elevated circulating levels of C-C chemokines in patients with congestive heart failure Circulation 97 1998 1136 1143
91. E.J. Birks, N. Latif, V. Owen, C. Bowles, L.E. Felkin, A.J. Mullen, A. Khaghani, P.J. Barton, J.M. Polak, J.R. Pepper, N.R. Banner, and M.H. Yacoub Quantitative myocardial cytokine expression and activation of the apoptotic pathway in patients who require left ventricular assist devices Circulation 104 2001 I233 I240
92. M. Testa, M. Yeh, P. Lee, R. Fanelli, F. Loperfido, J.W. Berman, and T.H. LeJemtel Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension J. Am. Coll. Cardiol. 28 1996 964 971
93. C. Stumpf, C. Lehner, D. Raaz, A. Yilmaz, T. Anger, W.G. Daniel, and C.D. Garlichs Platelets contribute to enhanced MCP-1 levels in patients with chronic heart failure Heart 94 2008 65 69
94. J. Haft, W. Armstrong, D.B. Dyke, K.D. Aaronson, T.M. Koelling, D.J. Farrar, and F.D. Pagani Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices Circulation 116 2007 I8 15
95. B.E. Jaski, R.J. Lingle, J. Kim, K.R. Branch, R. Goldsmith, M.R. Johnson, J.R. Lahpor, T.B. Icenogle, I. Pina, R. Adamson, L.K. Favrot, and W.P. Dembitsky Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial J. Heart Lung Transplant. 18 1999 1031 1040
96. R.V. Pruijsten, N. de Jonge, J.H. Kirkels, C. Klopping, P.A. Doevendans, A. Oosterom, H. Kemperman, and J.R. Lahpor Left ventricular assist device: a functional comparison with heart transplantation Neth. Heart J. 16 2008 41 46
97. N. de Jonge, H. Kirkels, J.R. Lahpor, C. Klopping, E.J. Hulzebos, A.B. de la Riviere, and E.O. Robles de Medina Exercise performance in patients with end-stage heart failure after implantation of a left ventricular assist device and after heart transplantation: an outlook for permanent assisting? J. Am. Coll. Cardiol. 37 2001 1794 1799
98. M.A. Simon, R.L. Kormos, J.,. Gorcsan 3rd, K. Dohi, S. Winowich, E. Stanford, L. Carozza, and S. Murali Differential exercise performance on ventricular assist device support J. Heart Lung Transplant. 24 2005 1506 1512
99. L. Gullestad, J. Myers, T. Edvardsen, J. Kjekshus, O. Geiran, and S. Simonsen Predictors of exercise capacity and the impact of angiographic coronary artery disease in heart transplant recipients Am. Heart J. 147 2004 49 54
100. R. Carter, O.A. Al-Rawas, A. Stevenson, T. Mcdonagh, and R.D. Stevenson Exercise responses following heart transplantation: 5 year follow-up Scott. Med. J. 51 2006 6 14
101. T.C. Leung, K.V. Ballman, T.G. Allison, J.A. Wagner, L.J. Olson, R.P. Frantz, B.S. Edwards, J.A. Dearani, R.C. Daly, C.G. McGregor, and R.J. Rodeheffer Clinical predictors of exercise capacity 1 year after cardiac transplantation J. Heart Lung Transplant. 22 2003 16 27
102. J. Myers, O. Geiran, S. Simonsen, A. Ghuyoumi, and L. Gullestad Clinical and exercise test determinants of survival after cardiac transplantation Chest 124 2003 2000 2005
103. J. Myers, L. Gullestad, D. Bellin, H. Ross, R. Vagelos, and M. Fowler Physical activity patterns and exercise performance in cardiac transplant recipients J. Cardpulm. Rehabil. 23 2003 100 106
104. L. Grosman-Rimon, M.A. McDonald, S. Pollock Bar-Ziv, I. Jacobs, L.C. Tumiati, D.Z. Cherney, and V. Rao Chronotropic incompetence, impaired exercise capacity, and inflammation in recipients of continuous-flow left ventricular assist devices J. Heart Lung Transplant. 32 2013 930 932
105. J. Nessler, B. Nessler, M. Kitlinski, A. Gackowski, W. Piwowarska, and M. Stepniewski Concentration of BNP, endothelin 1, pro-inflammatory cytokines (TNF-alpha, IL-6) and exercise capacity in patients with heart failure treated with carvedilol Kardiol. Pol. 66 2008 144 151 (discussion 152-3)
106. S. Adamopoulos, J. Parissis, D. Karatzas, C. Kroupis, M. Georgiadis, G. Karavolias, J. Paraskevaidis, K. Koniavitou, A.J. Coats, and D.T. Kremastinos Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure J. Am. Coll. Cardiol. 39 2002 653 663
107. S. Adamopoulos, J. Parissis, C. Kroupis, M. Georgiadis, D. Karatzas, G. Karavolias, K. Koniavitou, A.J. Coats, and D.T. Kremastinos Physical training reduces peripheral markers of inflammation in patients with chronic heart failure Eur. Heart J. 22 2001 791 797